MedTech Terms
    The authoritative reference
    All terms

    Class III Device

    FDA's highest-risk device class, generally requiring PMA.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026

    Definition

    Class III devices are those that support or sustain human life, are of substantial importance in preventing impairment of human health, or present a potential, unreasonable risk of illness or injury. They generally require PMA.
    What the regulation says
    Regulatory bodies, such as the FDA in 21 CFR 860.3, classify MedTech devices based on their risk to the patient and/or user. Class III devices are considered the highest risk and are subject to the most stringent regulatory controls, including premarket approval (PMA). The EU MDR, in Article 51 and Annex IX, outlines similar conformity assessment procedures for devices in its highest risk class, Class III.

    What this means in practice

    Examples include implantable defibrillators and life-supporting devices. Class III devices undergo the most stringent regulatory review.

    Examples

    • An implantable cardioverter-defibrillator (ICD) is a Class III device because it sustains life by monitoring heart rhythms and delivering electrical shocks if necessary.
    • A prosthetic heart valve is classified as Class III due to its critical role in preventing impairment of human health and the potential serious risks associated with its failure.
    • A high-risk in vitro diagnostic (IVD) test, such as one for screening blood donations for HIV, is a Class III device because an inaccurate result could lead to serious public health consequences.
    Common pitfalls
    • A common pitfall is misinterpreting the criteria for Class III, assuming only "life-sustaining" devices qualify, missing those preventing impairment or posing unreasonable risk.
    • Another mistake is underestimating the time and resources required for a Class III PMA submission, leading to significant project delays.
    • Failing to adequately address clinical evidence requirements for Class III devices is a frequent pitfall, as these devices demand robust safety and effectiveness data.
    • Thinking a device is Class II solely because it is not implantable or life-supporting can be a pitfall, as other risk factors can elevate classification.
    • Incorrectly applying predicates for substantial equivalence to Class III devices, where PMA is typically required, is a common error.

    Frequently asked questions

    The primary regulatory pathway for Class III devices in the United States is Premarket Approval (PMA), as outlined by the FDA. This involves a comprehensive review of scientific evidence to ensure safety and effectiveness.

    Cross-references

    See also

    Closely related context worth reading.

    Grouped by theme

    Primary references

    3 sources
    Link health: 3 verified· last checked 2026-06-20
    FDA·1European Commission·1IMDRF·1
    1. 1
      FDA - Medical Devices
      Verified
      FDAfda.gov
    2. 2
      European Commission - Medical Devices
      Verified
      European Commissionhealth.ec.europa.eu
    3. 3
      IMDRF Documents
      Verified
      IMDRFimdrf.org

    Inline markers like [1] jump to the matching reference above.